• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Robert Langer

red and purple piggy banks
Biotech

Biotech veteran Robert Langer joins son launching new VC

The father and son duo Robert and Michael Langer want to back “visionary founders” at the intersection of technology and biology.
Zoey Becker Sep 18, 2025 3:15pm
photo of a sign labeled closed on a business window

Langer spinout Lyndra begins winding down, lays off staff

Mar 27, 2025 10:58am
Robert Langer

Langer steps down from Moderna board after 14 years

Jul 23, 2024 12:18pm
Cells

Satellite Bio lifts off with $110M to make implantable tissues

Apr 20, 2022 8:06am
Jeremy Levin

Ovid staff shuffle reads like a who's who of Big Pharma

Jul 9, 2021 9:50am
Jeremy Levin - Credit Kelly Boothe agent of Ovid Therapeutics - Own work - CC BY-SA 40

Ovid plans to shop with Takeda bucks after shedding lead asset

Apr 22, 2021 9:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings